Literature DB >> 8307448

Why measure C reactive protein?

M Z Mazlam1, H J Hodgson.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8307448      PMCID： PMC1374622          DOI： 10.1136/gut.35.1.5

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  40 in total

Review 1.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

2.  Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Authors:  E A Fagan; R F Dyck; P N Maton; H J Hodgson; V S Chadwick; A Petrie; M B Pepys
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

Review 3.  Assessment of drug therapy in inflammatory bowel disease.

Authors:  H J Hodgson
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 4.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  C-reactive protein and the acute-phase response.

Authors:  I Kushner; H Gewurz; M D Benson
Journal:  J Lab Clin Med       Date:  1981-06

Review 6.  C-reactive protein and the acute phase response.

Authors:  H Gewurz; C Mold; J Siegel; B Fiedel
Journal:  Adv Intern Med       Date:  1982

7.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

8.  C-reactive protein in right iliac fossa pain.

Authors:  A H Davies; F Bernau; A Salisbury; R G Souter
Journal:  J R Coll Surg Edinb       Date:  1991-08

9.  Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.

Authors:  I Kushner; G Feldmann
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  The liver as the site of C-reactive protein formation.

Authors:  J Hurlimann; G J Thorbecke; G M Hochwald
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307
View more
  12 in total

1.  Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target?

Authors:  I G Martin; S G Cutts; K Birbeck; S Gray; P Quirke
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".

Authors:  R G Watson; T C Tham; B T Johnston; N I McDougall
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 3.  Vitamin C and gastric cancer: supplements for some or fruit for all?

Authors:  P O'Toole; M Lombard
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

Review 4.  Laboratory markers in ulcerative colitis: Current insights and future advances.

Authors:  Michele Cioffi; Antonella De Rosa; Rosalba Serao; Ilaria Picone; Maria Teresa Vietri
Journal:  World J Gastrointest Pathophysiol       Date:  2015-02-15

5.  Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.

Authors:  Motoaki Kuriyama; Jun Kato; Koji Takemoto; Sakiko Hiraoka; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

6.  Soluble adhesion molecules in inflammatory bowel disease.

Authors:  M G Goggins; J Goh; M A O'Connell; D G Weir; D Kelleher; N Mahmud
Journal:  Ir J Med Sci       Date:  2001 Apr-Jun       Impact factor: 1.568

7.  A simple method for assessing intestinal inflammation in Crohn's disease.

Authors:  J Tibble; K Teahon; B Thjodleifsson; A Roseth; G Sigthorsson; S Bridger; R Foster; R Sherwood; M Fagerhol; I Bjarnason
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 8.  Dietary nucleotides and gut mucosal defence.

Authors:  G K Grimble
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls.

Authors:  S C Bischoff; S Schwengberg; K Wordelmann; A Weimann; R Raab; M P Manns
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

10.  Anti-Ulcerative Effect of Curcumin-Galactomannoside Complex on Acetic Acid-Induced Experimental Model by Inhibiting Inflammation and Oxidative Stress.

Authors:  S Sheethal; M Ratheesh; Svenia P Jose; S Asha; I M Krishnakumar; S Sandya; B Girishkumar; John Grace
Journal:  Inflammation       Date:  2020-08       Impact factor: 4.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.